pharmaphorum

OCTOBER 12, 2022

AstraZeneca has teamed up with DNA sequencing giant Illumina on a new programme that will use artificial intelligence to find new targets for drug discovery by sifting through vast arrays of data generated from “omics” studies.

Genome 62

Genome Genomics DNA Drugs 62

pharmaphorum

JANUARY 14, 2021

Healthcare technology firm Seqster has introduced a new version of its service that aims to help pharma companies work with patients’ data while on virtual clinical trials. service will allow secure access to real-world data from electronic health records (EHRs), DNA analysis and fitness wearables. The new Seqster 7.1

Trials 52

Trials Clinical Trials Clinical Trials Pharma Companies 52

Drug Discovery World

AUGUST 3, 2023

In the first article, Troy Groetken of intellectual property and technology law firm McAndrews, Held & Malloy tells Lu Rahman how pharma companies can take this data from where it currently stands (drug design and development) to a more clinical level. ” and “ Why a recent advancement is a giant leap for human genomics ”.

Big Data 52

Big Data Genome Genomics Pharma Companies 52

XTalks

DECEMBER 13, 2023

Now, let’s delve into the list of the top ten fastest growing biotech companies in 2023, ranked by their compound annual growth rate (CAGR). These companies were identified through The Americas’ Fastest-Growing Companies 2023 list by the Financial Times. In the third quarter of 2023, the company’s revenue surged to $63.7

Genetics 111

Genetics Vaccination Vaccine DNA 111

pharmaphorum

DECEMBER 9, 2022

The PharmaStars accelerator was set up last year to help bridge the gap between digital health start-ups and potential pharma partners, which can be instrumental in making sure their technologies meet their potential – and help them to navigate the challenges of developing them in the highly regulated healthcare environment.

Life Science 52

Life Science DNA Genome Genomics 52

XTalks

DECEMBER 20, 2023

In 2024, pharma companies and emerging biotechs will improve candidate safety profiles and reduce off-target effects by exploiting predictive intelligence unlocked by AI,” she predicts. CRISPR Gene Editing Therapeutics CRISPR/Cas-9 technology makes lists like this almost every year, and for good reason.

Life Science 119

Life Science Gene Editing Development Clinical Trials 119

pharmaphorum

NOVEMBER 3, 2022

If approved, gepotidacin (GSK2140944) could become the first drug in a new class of oral antibiotics for uncomplicated urinary tract infections (UTIs) in more than 20 years, according to the pharma group, which plans to submit the data to the FDA in the first half of next year.

Development 98

Development DNA Drugs Pharma Companies 98

pharmaphorum

JULY 5, 2021

The new deal will assists the company’s focus “on advancing and innovating Parexel to meet our customers’ needs across the evolving clinical development landscape,” he added. ” The deal is subject to the usual conditions, including receipt of various approvals from regulators around the world.

Clinical Trials 62

Clinical Trials Clinical Trials Regulation Trials 62

The Pharma Data

DECEMBER 16, 2020

the company is exploring other ways to combat COVID-19. AstraZeneca is partnering with INOVIO and multiple universities to advance INOVIO’s innovative DNA-encoded monoclonal antibody (dMAb) technology. and will leverage a major COVID-19 vaccine partnership the company struck with the U.K. The study will be conducted in the U.K.

Vaccination 52

Vaccination Vaccine DNA Antibody 52

Drug Discovery World

SEPTEMBER 29, 2022

Big pharma companies routinely maintain their own decks of upwards of millions of compounds. However, the majority of drug discovery companies either do not own a compound library or maintain a focused set of compounds for their targets of interest. Conclusion.

Reagent 52

Reagent DNA Scientist Drugs 52

Drug Discovery World

OCTOBER 7, 2022

TH : Increasingly, large pharma companies need scale, agility and access to academic partnerships to succeed. It is unsurprising that many pharma companies are increasingly keen to work with academia or academic spin-out. companies to supplement their own R&D; most novel ideas stem from academia. Tony Hickson.

HR 52

HR Research Drugs Development 52

XTalks

DECEMBER 27, 2022

The pharma company will expand its manufacturing capacity for commercial scale vector production for oncology treatment. Then, the cells translate the DNA sequence of the gene and secrete high amounts of the protein interferon alfa-2b. This protein is naturally occurring in the human body and the body uses it to fight cancer.

Gene Therapy 52

Gene Therapy FDA Approval Gene Clinical Trials 52

Drug Discovery World

JANUARY 21, 2024

He will also explain the importance of this innovation as a way to mitigate the high failure rates in clinical trials, which historically see 92% of drugs fail despite passing animal tests, leading to significant financial and time losses in the industry (approximately $53 billion for pharma companies annually).

Protein 52

Protein Vaccination Vaccine Development 52

pharmaphorum

JANUARY 29, 2021

‘Cutting edge’ is, for once, a truly apt description when it comes to gene editing – both because the field is pushing medicine into areas we might never have dreamed possible, and because these technologies involve literally cutting DNA at a specific point in the genome. The company’s primary technology is its zinc finger (ZF) platform.

Gene Editing 142

Gene Editing Gene Gene Therapy In-Vivo 142

Drug Discovery World

FEBRUARY 6, 2024

Biopharma and biotech companies without these capabilities are keen to harness these technologies and the number of strategic partnerships with such companies is accelerating at an unprecedented rate.

Marketing 69

Marketing Medicine Genome Genomics 69

pharmaphorum

SEPTEMBER 8, 2022

However, there is a difference between the two: the toxic payloads of ADCs need to be absorbed into cancer cells, whereas radiopharmaceuticals can still do damage even when only bound to the cancer, and are particularly sensitive to radiation-induced DNA damage. Investment is flowing.

Manufacturing 95

Manufacturing Development Drugs Antibody 95

pharmaphorum

DECEMBER 21, 2020

Compared with many of the established names in pharma these companies are young upstarts but they have managed to achieve what other big names in the industry have failed to do and harness the power of mRNA to make medicine. He told pharmaphorum: “They are very good doctors, scientists and entrepreneurs.

Vaccination 85

Vaccination Vaccine Doctors Doctor 85

Drug Discovery World

AUGUST 8, 2023

According to a report by Deloitte, globally India is the third largest in the world by volume and 11th by value, comprising over 3,000 pharma companies and 10,500 manufacturing facilities 2. To many, the country is referred to as the ‘pharmacy of the world’. So, what is driving this success, and will it continue?

Research 52

Research Drugs Genome Genomics 52

Delveinsight

JULY 29, 2020

British-Swedish pharma company AstraZeneca in collaboration with Jenner Institute (Oxford University) is working on Covid-19 vaccine ChAdOx1 nCoV-19 /AZD1222. Based in Ahmedabad, Zydus Cadila is one of the top most pharma companies in the Indian pharmaceutical industry. Zydus Cadila ( ZyCoV-D ).

Vaccination 62

Vaccination Vaccine Clinical Trials Clinical Trials 62

The Pharma Data

OCTOBER 14, 2020

Under the terms of the non-exclusive agreement FASMAC acquires the right to use CRISPR/Cas9 technology and commercialize tools and reagents associated with it.

Clinical Trials 52

Clinical Trials Clinical Trials Manufacturing Trials 52

Drug Discovery World

OCTOBER 16, 2023

Despite the overall reduction in major pharma R&D centres in the UK, global pharma companies continue to engage with academic and biotech organisations here, particularly in hotspots such as the Golden Triangle, the Northwest, and Scotland, through the strong networks that have been developed between these organisations.

Drugs 75

Drugs Life Science Gene Therapy Genome 75

XTalks

DECEMBER 22, 2021

The gene-editing tool CRISPR edits DNA using specialized strands of guide RNA and endogenous cellular mechanisms of RNA interference. To develop these novel RNA-based therapeutics, we saw a number of big pharma companies team up with smaller biotechs focused on developing RNA-based therapeutics.

Life Science 98

Life Science RNA Vaccination Vaccine 98

Pharma Marketing Network

NOVEMBER 4, 2020

RJ (PMN): One of the things I’m thinking about as you’re describing the kind of multiple permutations that could evolve and I’ve seen this in some of the examples you say to be for about like AI creating its own musical composers which have gotten really quite good and and fascinating. RJ (PMN): Fascinating stuff.

Branding 52

Branding Marketing Regulation Production 52

XTalks

OCTOBER 1, 2020

At Nurix, Dr. Hansen focuses on establishing the company’s DNA-encoded library technology platform for small molecule identification and leading the discovery organization. However, within industry organizations such as large pharma companies, funding tends to differ at each stage of research and development.

Scientist 52

Scientist In-Vitro Research Life Science 52

The Pharma Data

MAY 13, 2021

Unfortunately, I learned the hard way that the “Big Pharma” companies don’t care about their patients. Stimulates DNA and RNA synthesis. Why do doctors prescribe drugs which are so powerful they require a second set of medication just to deal with the side effects! It’s all about the bottom line, at any cost.

Pharmacy 52

Pharmacy Production Doctors Doctor 52